首页> 美国卫生研究院文献>PLoS Clinical Trials >Analysis of novel RUNX2 mutations in Chinese patients with cleidocranial dysplasia
【2h】

Analysis of novel RUNX2 mutations in Chinese patients with cleidocranial dysplasia

机译:中国颅脑发育不良患者新的RUNX2突变分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cleidocranial dysplasia (CCD) is an autosomal dominant inheritable skeletal disorder characterized by cranial dysplasia, clavicle hypoplasia and dental abnormalities. This disease is mainly caused by heterozygous mutations in RUNX2, a gene that encodes an osteoblast-specific transcription factor. In the present study, mutational analyses of RUNX2 gene were performed on four unrelated Chinese patients with CCD. Four different RUNX2 mutations were detected in these patients, including one nonsense mutation (c.199C>T p.Q67X) and three missense mutations (c.338T>G p.L113R, c.557G>C p.R186T and c.673C>T p.R225W). Among them, two mutations (c.199C>T p.Q67X and c.557G>C p.R186T) were novel and the other two had been reported in previous literatures. Except for Q67X mutation located in the Q/A domain, other three mutations were clustered within the highly conserved Runt domain. Green fluorescent protein (GFP) and RUNX2 fusion protein analyses in vitro showed that nuclear accumulation of RUNX2 protein was disturbed by Q67X mutation, while the other two mutations (c.338T>G p.L113R and c.557G>C p.R186T) had no effects on the subcellular distribution of RUNX2. Luciferase reporter assay demonstrated that all the three novel RUNX2 mutations significantly reduced the transactivation activity of RUNX2 on osteocalcin promoter. Our findings enrich the evidence of molecular genetics that the mutations of RUNX2 gene are responsible for CCD.
机译:颅骨发育不良(CCD)是一种常染色体显性遗传遗传性骨骼疾病,其特征是颅骨发育不良,锁骨发育不良和牙齿异常。该疾病主要是由RUNX2中的杂合突变引起的,RUNX2是一种编码成骨细胞特异性转录因子的基因。在本研究中,对4例中国无关的CCD患者进行了RUNX2基因的突变分析。在这些患者中检测到四个不同的RUNX2突变,包括一个无意义突变(c.199C> T p.Q67X)和三个错义突变(c.338T> G p.L113R,c.557G> C p.R186T和c.673C > T p.R225W)。其中,两个突变(c.199C> T p.Q67X和c.557G> C p.R186T)是新突变,另外两个已在以前的文献中报道过。除了位于Q / A域中的Q67X突变外,其他三个突变都聚集在高度保守的Runt域中。绿色荧光蛋白(GFP)和RUNX2融合蛋白的体外分析表明,RUNX2蛋白的核积累受到Q67X突变的干扰,而其他两个突变(c.338T> G p.L113R和c.557G> C p.R186T)对RUNX2的亚细胞分布没有影响。萤光素酶报告基因检测证明,这三个新的RUNX2突变均显着降低RUNX2对骨钙素启动子的反式激活活性。我们的发现丰富了分子遗传学的证据,证明RUNX2基因的突变是CCD的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号